MRNA
Moderna, Inc.Company with tickers: MRNA
CIK
1682852
CUSIP
60770K107
Shares Outstanding
396,786,259
Website
https://www.modernatx.com
Investor Relations
https://investors.modernatx.com/
13F Activity (30d)
57 filings
15 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding MRNA
452 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Growth Fund of America | — | 12,500,000 | $669,625,000 | 0.20% | Long | 2026-02-28 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 11,295,961 | $573,834,819 | 0.03% | Long | 2026-03-31 | |
| VANGUARD 500 INDEX FUND | — | 8,838,135 | $448,977,258 | 0.03% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 8,195,823 | $416,347,808 | 0.25% | Long | 2026-03-31 | |
| VANGUARD INTERNATIONAL GROWTH FUND | — | 5,967,346 | $319,670,725 | 0.71% | Long | 2026-02-28 | |
| VANGUARD SMALL-CAP VALUE INDEX FUND | — | 5,219,030 | $265,126,724 | 0.44% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 4,812,597 | $257,810,821 | 0.31% | Long | 2026-02-28 | |
| Fidelity 500 Index Fund | — | 4,424,989 | $237,046,661 | 0.03% | Long | 2026-02-28 | |
| iShares Core S&P 500 ETF | — | 4,472,808 | $227,218,646 | 0.03% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | SPY | 4,051,659 | $205,824,277 | 0.03% | Long | 2026-03-31 | |
| Growth Fund | — | 4,000,000 | $203,200,000 | 0.41% | Long | 2026-03-31 | |
| Fidelity Contrafund | — | 3,434,606 | $174,477,985 | 0.11% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 2,692,459 | $136,776,917 | 1.68% | Long | 2026-03-31 | |
| VANGUARD U.S. GROWTH FUND | — | 2,550,076 | $136,607,571 | 0.31% | Long | 2026-02-28 | |
| State Street(R) Health Care Select Sector SPDR(R) ETF | — | 2,530,630 | $128,556,004 | 0.33% | Long | 2026-03-31 | |
| First Trust NYSE Arca Biotechnology Index Fund | — | 2,351,289 | $119,445,481 | 5.26% | Long | 2026-03-31 | |
| Fidelity Puritan Fund | — | 2,214,200 | $118,614,694 | 0.37% | Long | 2026-02-28 | |
| VANGUARD INSTITUTIONAL INDEX FUND | — | 1,958,337 | $99,483,520 | 0.03% | Long | 2026-03-31 | |
| Capital Group Growth ETF | — | 1,759,424 | $94,252,344 | 0.47% | Long | 2026-02-28 | |
| Select Health Care Portfolio | — | 1,600,000 | $85,712,000 | 1.38% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 1,513,720 | $76,896,976 | 1.03% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 1,432,529 | $76,740,579 | 1.43% | Long | 2026-02-28 | |
| iShares Russell Mid-Cap ETF | — | 1,367,541 | $69,471,083 | 0.14% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 1,281,154 | $68,631,420 | 0.30% | Long | 2026-02-28 | |
| Fidelity Series Growth Company Fund | — | 1,218,341 | $65,266,527 | 0.31% | Long | 2026-02-28 | |
| Fidelity Advisor Equity Growth Fund | — | 1,218,053 | $65,251,099 | 0.54% | Long | 2026-02-28 | |
| VIP Growth Portfolio | — | 1,125,011 | $57,150,559 | 0.54% | Long | 2026-03-31 | |
| Schwab U.S. Mid-Cap ETF | — | 940,525 | $50,383,924 | 0.37% | Long | 2026-02-28 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 910,261 | $48,762,682 | 0.24% | Long | 2026-02-28 | |
| Fidelity Balanced Fund | — | 897,200 | $48,063,004 | 0.08% | Long | 2026-02-28 | |
| Schwab Fundamental U.S. Large Company ETF | — | 864,155 | $46,292,783 | 0.19% | Long | 2026-02-28 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 833,433 | $44,647,006 | 0.02% | Long | 2026-02-28 | |
| iShares Russell 1000 Value ETF | — | 820,324 | $41,672,459 | 0.06% | Long | 2026-03-31 | |
| Federated Hermes MDT Market Neutral Fund | — | 777,374 | $39,490,599 | 1.75% | Long | 2026-03-31 | |
| Fidelity Contrafund K6 | — | 761,678 | $38,693,242 | 0.12% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | — | 733,805 | $37,277,294 | 0.03% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 688,800 | $36,899,016 | 2.43% | Long | 2026-02-28 | |
| Schwab U.S. Large-Cap Growth ETF | — | 667,763 | $35,772,064 | 0.07% | Long | 2026-02-28 | |
| Fidelity Total Market Index Fund | — | 652,219 | $34,939,372 | 0.03% | Long | 2026-02-28 | |
| Fidelity Growth Discovery Fund | — | 611,560 | $31,067,248 | 0.54% | Long | 2026-03-31 | |
| iShares S&P 500 Value ETF | — | 600,177 | $30,488,992 | 0.07% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 560,799 | $30,042,002 | 0.46% | Long | 2026-02-27 | |
| BlackRock Health Sciences Term Trust | BMEZ | 549,814 | $27,930,551 | 2.76% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 513,519 | $27,509,213 | 0.03% | Long | 2026-02-28 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 527,555 | $26,799,794 | 0.25% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap Value ETF | — | 515,041 | $26,164,083 | 0.18% | Long | 2026-03-31 | |
| VANGUARD STRATEGIC EQUITY FUND | — | 504,078 | $25,607,162 | 0.25% | Long | 2026-03-31 | |
| Fidelity U.S. Equity Central Fund | — | 500,000 | $25,400,000 | 0.12% | Long | 2026-03-31 | |
| Invesco Equally-Weighted S&P 500 Fund | — | 449,463 | $24,077,733 | 0.34% | Long | 2026-02-28 | |
| Fidelity Advisor New Insights Fund | — | 450,300 | $22,875,240 | 0.10% | Long | 2026-03-31 |
Showing 1–50 of 452 positions